Eccrine Neoplasm — Trials

Eccrine Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

8 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–1 of 1 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT01131325	Study of Nilotinib in Ph+ CML-CP Patients With Low Imatinib Trough Plasma Concentrations(MACS1148)	terminated	Phase 4	3	Novartis PharmaceuticalsINDUSTRY	1	May 20, 2021	clinicaltrials

Data updated 22 days agoSource updated May 20, 2021source: clinicaltrials